NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email As Washington considers a new tax targeting highly paid workers, debate rages on over its potential impacts on businesses and the state’s startup culture.Read More